Legha, S S <br/><br/>
Evaluation of interleukin-2 administered by continuous infusion in patients with metastatic melanoma.  [electronic resource] 

 -  Cancer  Jan 1996 
 - 89-96 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0008-543X 
<br/><br/><label>Standard No.: </label>10.1002/(SICI)1097-0142(19960101)77:1<89::AID-CNCR15>3.0.CO;2-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Dose-Response Relationship, Drug<br/>Female<br/>Humans<br/>Infusions, Intravenous<br/>Interleukin-2--administration & dosage<br/>Male<br/>Melanoma--drug therapy<br/>Middle Aged<br/>Survival Rate